Melanoma: A model for testing new agents in combination therapies

Overview of attention for article published in Journal of Translational Medicine, April 2010

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (72nd percentile)

Mentioned by

patent: 5 patents

Citations

dimensions_citation: 41 Dimensions

Readers on

mendeley: 49 Mendeley
citeulike: 2 CiteULike

Summary Patents Dimensions citations

So far, Altmetric has seen 5 patents that reference this research output.

Combination of anti-KIR and anti-CTLA-4 antibodies to treat cancer

Grant US-10688180-B2

United States of America

Combination of anti-KIR and anti-CTLA-4 antibodies to treat cancer

Grant US-9789182-B2

United States of America

COMBINATION OF ANTI-KIR AND ANTI-CTLA-4 ANTIBODIES TO TREAT CANCER

Application WO-2014066532-A1

World Intellectual Property Organisation (WIPO)

COMBINATIONS (CATECHINS AND METHOTREXATE) FOR USE IN THE TREATMENT OF MELANOMAS

Application WO-2014029669-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity, including 1 additional patents.